About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Cognitive Screening in Lung Cancer Patients | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT06727370

Cognitive Screening in Lung Cancer Patients

This study aims to investigate the occurrence of cancer and adjuvant therapy-related cognitive impairment in patients with both NSCLC and SCLC. The primary endpoint measure will be the presence of cog...

Lead sponsor: European Institute of Oncology•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Gabriella Pravettoni

CONTACT

+39025489731 gabriella.pravettoni@ieo.it

Lorenzo Conti

CONTACT

Sponsors

Lead Sponsor

European Institute of Oncology

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Small-cell and non-small-cell lung cancer (stage I, II, III, IV)
•Age ≥ 18 years
•Patients able to speak and read the local language(s) fluently
•Acceptance and signature of informed consent

Exclusion Criteria

•Age ≥ 70
•Presence of brain metastases
•Patients with concomitant neurological or psychiatric disorders.
•Patients undergoing brain radiotherapy
•Previous diagnosis of lung cancer

Related studies

RECRUITINGPhase 2

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

NCT05967689 · Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease

NCT07647575 · Nontuberculous Mycobacterial Lung Disease, Bronchiectasis

Acute Effects of Visual Feedback-Assisted Inspiratory Muscle Training After Lobectomy

NCT07646288 · VATS, Respiratory Muscles, and more

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

NCT07516379 · Lung Transplant, End Stage Lung Disease, and more

RECRUITINGPhase 2

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

NCT07489066 · Carcinoma, Non-Small-Cell Lung, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 10, 2024Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment200

Start dateJan 2024

Last updatedDec 10, 2024

Condition

Lung Disease NSCLC (Non-small Cell Lung Cancer)SCLC

Locations shown

Istituto Europeo di Oncologia

Milan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 10, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions